DNTH Exercise Disclosure
Carr Edward · SEC Form 4 · Filed Sep 18, 2026
Exercise
Calculated transaction value
$0
Carr Edward Chief Accounting Officer
DNTH
Transaction date
Sep 17, 2026
Public filing date
Sep 18, 2026
Filing lag
Filed 1 day later
DNTH daily price context
Close on/before transaction
$101.12
Sep 17, 2026
Close before public filing
$101.12
Sep 17, 2026
Return since public filing
-4.6%
Through Sep 21, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (Right to Buy) on Common Stock
- Quantity / price
- 20,000 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001273351-26-000006
Filing cohort
Transactions in this filing
Showing 7 of 7
Trades
7
Issuers
1
Estimated value
$2.39M
Buys / sales
0 / 5
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Dianthus Therapeutics, Inc. /de/ DNTH | Exercise | Sep 17, 2026 | $357.6K |
| Dianthus Therapeutics, Inc. /de/ DNTH | Sale | Sep 17, 2026 | $796.21K |
| Dianthus Therapeutics, Inc. /de/ DNTH | Sale | Sep 17, 2026 | $686.38K |
| Dianthus Therapeutics, Inc. /de/ DNTH | Sale | Sep 17, 2026 | $358.47K |
| Dianthus Therapeutics, Inc. /de/ DNTH | Sale | Sep 17, 2026 | $113.52K |
| Dianthus Therapeutics, Inc. /de/ DNTH | Sale | Sep 17, 2026 | $73.07K |
| Dianthus Therapeutics, Inc. /de/ DNTH Current | Exercise | Sep 17, 2026 | $0 |